Inhibitors of bruton’s tyrosine kinase

    公开(公告)号:NZ599396A

    公开(公告)日:2014-03-28

    申请号:NZ59939610

    申请日:2010-10-12

    Abstract: NZ 599396 The disclosure relates to pyrazolo-pyrimidine derivatives of formula (II) that are inhibitors of bruton’s tyrosine kinase (Btk), wherein the variables are as defined in the specification. The disclosure also relates to methods for synthesizing such inhibitors, and methods, assays and systems for determining an appropriate inhibitor of a protein, including a kinase. These compounds are suitable for treating an autoimmune disease or condition, a heteroimmune disease or condition, cancers including B-cell proliferative disorder is diffuse large B cell lymphoma, follicular lymphoma or chronic lymphocytic leukemia, mastocytosis, osteoporosis, and an inflammatory disease or condition.

Patent Agency Ranking